Foundation CEO @SusanWinckler and @US_FDA’s @fdacderdirector welcome attendees to “Natural History Studies and Registries in the Development of Rare Diseases Treatments,” our hybrid public workshop in collaboration with FDA and @NIH.
In what’s called the best tradition in college sports, @HarrySmith shares the history of people in the Kinnick Stadium waving to patients at Stead Family Children's Hospital overlooking the field — and meets a player in a full-circle moment.
Today, for #TransDayofVisibility, the transgender pride flag is flying proudly outside the HHS Headquarters in Washington, D.C. – for the second year in a row.
Today and always, transgender health care is health care. Period. #TDOV
Today, FDA approved a naloxone hydrochloride nasal spray for over-the-counter, nonprescription, use – the first naloxone product approved for use without a prescription. https://t.co/KA9OSjDKiP
Time and time again, when Melissa Corrigan, RPh, CAE, FAPhA, FASHP, is invited to participate, speak, or serve, the call is answered. Join us in congratulating our dear friend for receiving the 50 Most Influential Leaders in Pharmacy 2023 Award! https://t.co/mQQtSqPRYp🤩🥳
Hope…Determination…Freedom…Life-changing. Just some of the words used by patients sharing their perspectives on Accelerated Approval in our virtual public meeting.
I can’t think of any individual more deserving of @ReaganUdall’s Leadership Award than the FDA’s director of the Center for Biologics Evaluation and Research, Dr. Peter Marks.
Wrapping up another day of learning...
Began exploring the COVID-screening goal
Then discussed guidance real-world data, concerning
Closed out with treatments aspiring COVID to control.
And yep, my brain is full.
https://t.co/3uIPJ5DgmE
Looking forward to this engaging conversation
How to advance drug research 'cross the nation
'Though still mid-pandemic
Some fixes are non-polemic
To good ideas, let's give some acceleration.
Join me on September 28 for the virtual FDA public workshop “Federal COVID-19 Response: Clinical Evaluation of Therapeutics Lessons Learned.” https://t.co/9GWyafRTTV
Some cancer patients need #expandedaccess to treatments still in testing. In our latest from Curious Dr. George, he asks 2 leaders from @reaganudall how their org helps docs navigate expanded access so patients can get the treatments they need:https://t.co/RlsZFXTDon @McneeLeaann
Last chance, last chance, to throw in a nomination
To identify candidates for our awards celebration.
Takes just a bit of time
To fill in a few lines,
Help us recognize leadership, advocacy, and innovation.
Help us honor the individuals, teams, and organizations behind public health breakthroughs. Nominate your hero or mentor before Friday for an Innovations in Regulatory Science Award. https://t.co/Mm4xTyboFH
Excited to speak at FDA's Science Forum
Where I am sure we will maintain appropriate decorum.
While celebrating science
And discussing regulatory reliance
Oh, researchers, we do adore 'em.
2021 FDA Science Forum Agenda https://t.co/nRsQwgSbPo
When Congress created us,
They said: Share your work!
Our Annual Meeting is today
And moderating it, a perk.
So log in and listen, be part of our network.
Still time to register for an update on all-things-FDA-Foundation!
https://t.co/Hn1yty2JFb